VitroScan
Pre-clinicalOur ex vivo drug response platform is proven effective for identifying and testing (new) drugs for cancer treatment, it is scalable, and very suitable for accurate testing of large number of patients' samples.
Founded
2015
Focus
Diagnostics
About
Our ex vivo drug response platform is proven effective for identifying and testing (new) drugs for cancer treatment, it is scalable, and very suitable for accurate testing of large number of patients' samples.
Company Info
TypePrivate
Founded2015
LocationRotterdam, Netherlands
StagePre-clinical
Contact
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile